The estimated Net Worth of Richard C Garrison is at least $18 Milion dollars as of 18 May 2009. Richard Garrison owns over 532 units of Vertex Pharmaceuticals stock worth over $17,789,932 and over the last 19 years Richard sold VRTX stock worth over $259,205.
Richard has made over 8 trades of the Vertex Pharmaceuticals stock since 2006, according to the Form 4 filled with the SEC. Most recently Richard sold 532 units of VRTX stock worth $15,135 on 18 May 2009.
The largest trade Richard's ever made was selling 2,258 units of Vertex Pharmaceuticals stock on 13 May 2008 worth over $61,395. On average, Richard trades about 587 units every 59 days since 2006. As of 18 May 2009 Richard still owns at least 37,473 units of Vertex Pharmaceuticals stock.
You can see the complete history of Richard Garrison stock trades at the bottom of the page.
Richard's mailing address filed with the SEC is C/O VERTEX PHARMACEUTICALS INCORPORATED, 130 WAVERLY STREET, CAMBRIDGE, MA, 02139.
Over the last 21 years, insiders at Vertex Pharmaceuticals have traded over $934,925,905 worth of Vertex Pharmaceuticals stock and bought 308,652 units worth $12,298,449 . The most active insiders traders include Lloyd Carney, Jeffrey M Leiden oraz Joshua S Boger. On average, Vertex Pharmaceuticals executives and independent directors trade stock every 5 days with the average trade being worth of $4,747,875. The most recent stock trade was executed by Jeffrey M Leiden on 30 August 2024, trading 3,784 units of VRTX stock currently worth $1,888,216.
Vertex Pharmaceuticals is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry.
Vertex Pharmaceuticals executives and other stock owners filed with the SEC include: